JonathanChengMD

Oncology • Philadelphia, PA

Physician

Join to view full profile

Dr. Cheng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cheng's full profile

Already have an account?

Office
333 Cottman Ave
Fox Chase Cancer Center
Philadelphia, PA 19111
Phone+1 215-728-6900

Fax+1 215-728-3639

Education & Training

Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1998 - 1999
University at BuffaloFellowship, Hematology and Medical Oncology, 1996 - 1998
University of MinnesotaResidency, Internal Medicine, 1992 - 1995
University of Minnesota Medical SchoolClass of 1992

Certifications & Licensure

PA State Medical License 1998 - 2024
MN State Medical License 1994 - 1997
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer Start of enrollment: 2000 May 01
Completed
Phase 2
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery Start of enrollment: 2007 Aug 01
Completed

Publications & Presentations

PubMed

Correction to: Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome.
Leonard R Henry, Elin Sigurdson, Eric A Ross, John S Lee, James C Watson
Annals of Surgical Oncology. 2021-12-01
Correction to: Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome.
Leonard R Henry, Elin Sigurdson, Eric A Ross, John S Lee, James C Watson
Annals of Surgical Oncology. 2021-12-01
6 citations
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radioth...
Patrick M Boland, Joshua E. Meyer, Adam C. Berger, Steven J. Cohen, Tzahi Neuman
American Journal of Clinical Oncology. 2017-08-01

Journal Articles

Pan-Tumor Genomic Biomarkers for PD-1 Checkpoint Blockade–Based Immunotherapy
Jonathan Cheng, Patrick A Ott, Elizabeth R Plimack, Antoni Ribas, Andrew Joe, Science Magazine

Press Mentions

According to New Multinational Survey, Healthcare Providers Believe Immunotherapy Has Potential to Positively Impact Earlier-Stage Cancer Treatment Landscape Across Tumor TypesSeptember 13th, 2021
MiR Scientific Snags BMS Melanoma, Genitourinary Commercial Leader for Cancer Detection TestAugust 13th, 2021
Bristol Myers, Yielding to FDA Pressure, Pulls Opdivo in Post-Nexavar Liver CancerJuly 26th, 2021
Join now to see all